50.200
+0,00%
2026-10-19
Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +25.0% | +7.0% | 2 / 3 | +2.8% | +5.41 pp | +9.40 pp | +20.6% | 0.13 | 9.99 | 191 | +2,8% | 106 | +23,8% | 9.99 | 10.36 | −3,6% |
| Pts | 4 | 0 | 8 | 0 | 12 | 12 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 50.200 (close price on 2026-10-19)EPS (TTM): 5.026
Financial charts
1.Revenue & growth
VND bn191Q2/26
1.Revenue & growth
VND bn191Q2/26
2.Profit & growth
VND bn105Q2/26
3.Profit mix (Penman)
VND bn424Q2/26
4.Margins & cost structure
%52.8%Q2/26
5.Returns & cash cycle
% · days24.9%Q2/26
6.Earnings quality & cash
VND bn357Q2/26
7.Asset structure
VND bn2.201Q2/26
8.Funding & debt health
VND bn · times2.201Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %10,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.505Q2/26
Adjusted EPS growth, latest quarter
25.0%
Average adjusted EPS growth, 3 quarters
7.0%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26